Table 2 In vitro antifungal activities of compounds 8a-q and 11
From: Design, synthesis and antimicrobial evaluation of novel 2-aryl-thiazolidin-4-one derivatives
Compound | MIC (μg/mL) | |||||
|---|---|---|---|---|---|---|
Ca | Cn | Ss | Tm | Af | Cp | |
8a | > 50 | > 50 | > 50 | 50 | > 50 | > 50 |
8b | > 50 | > 50 | > 50 | > 50 | > 50 | > 50 |
8c | > 50 | > 50 | > 50 | > 50 | > 50 | > 50 |
8d | > 50 | > 50 | > 50 | > 50 | > 50 | > 50 |
8e | > 50 | > 50 | > 50 | > 50 | > 50 | > 50 |
8f | > 50 | > 50 | > 50 | > 50 | > 50 | > 50 |
8g | > 50 | > 50 | 50 | 50 | > 50 | > 50 |
8h | > 50 | > 50 | 50 | 50 | > 50 | > 50 |
8i | > 50 | > 50 | 50 | 50 | > 50 | > 50 |
8j | > 50 | > 50 | > 50 | 50 | 50 | > 50 |
8k | > 50 | > 50 | > 50 | 50 | > 50 | > 50 |
8l | > 50 | > 50 | > 50 | 50 | > 50 | > 50 |
8m | > 50 | > 50 | > 50 | 50 | > 50 | > 50 |
8n | > 50 | > 50 | > 50 | 50 | > 50 | > 50 |
8o | > 50 | > 50 | > 50 | 50 | > 50 | > 50 |
8p | > 50 | > 50 | > 50 | 50 | > 50 | > 50 |
8q | > 50 | > 50 | > 50 | 50 | > 50 | > 50 |
11 | > 50 | > 50 | > 50 | > 50 | > 50 | > 50 |
Ketoconazole | 0.002 | 0.001 | 0.031 | 4.0 | 2.0 | 0.031 |
Fluconazole | 0.5 | 1.0 | 2.0 | 1.0 | 2.0 | 1.0 |